BURT A ADELMAN
CIK 1226283 · CMO & EVP, R&D · last filed 2025-07-28
BURT A ADELMAN is a CMO & EVP, R&D who has filed 35 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for VERV, was dated Jul 28, 2025. Across all open-market trades the lifetime net is −$21.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.76M
4
35
-$21.55M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) Delisted | Director | 0 | $11.13 | $0 | $354.4K | 8 | 2025-07-28 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 5 | 2020-06-12 |
| DYAX CORP (DYAX) Delisted | CMO & EVP, R&D | 0 | — | — | -$1.73M | 11 | 2016-01-22 |
| BIIB | EVP, Portfolio Strategy | 43,778 | $200.05 | $8.76M | -$20.17M | 11 | 2007-10-17 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | −428,326 | $0 | EDGAR |
| 2025-06-06 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-28 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-13 | Verve Therapeutics, Inc. (VERV) Delisted | Buy (P) | +10,000 | $121.5K | EDGAR |
| 2022-03-17 | Verve Therapeutics, Inc. (VERV) Delisted | Buy (P) | +4,000 | $85.5K | EDGAR |
| 2021-12-06 | Verve Therapeutics, Inc. (VERV) Delisted | Buy (P) | +4,700 | $147.3K | EDGAR |
| 2020-06-12 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-05 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |